Stock Financial Ratios


APHB / Ampliphi Biosciences Corp. financial ratios include Market Cap, Enterprise Value, Book Value, Quick Ratio, Current Ratio, NCAV, EBITDA, Profit Margin, Operating Margin, Return on Invested Capital (ROIC), Return on Assets (ROA), Return on Equity (ROE), Piotroski F-Score, Altman Z-Score, Beneish M Score and Kaplan-Zingales KZ-Index.

Valuation Metrics
Price0.92
Volume146,800.00
Market Cap ($M)8.08
Enterprise Value ($M)0.35
Book Value ($M)9.72
Book Value / Share0.99
Price / Book0.83
NCAV ($M)15.33
NCAV / Share1.56
Price / NCAV0.72
Income Statement (mra) ($M)
Revenue0.00
EBITDA-23.38
Net Income-18.84
Balance Sheet (mrq) ($M)
Cash & Equivalents7.72
Cash / Share0.79
Assets13.50
Liabilities3.26
Quick Ratio2.49
Current Ratio2.49
Management Effectiveness (mra)
Return on Invested Capital (ROIC)-1.94
Return on Assets (ROA)-1.05
Return on Equity (ROE)-1.94
Identifiers and Descriptors
CUSIP03211P103
Central Index Key (CIK)921114
Industry Groups
SIC 2836 - Biological Products, Except Diagnostic Substances (Biotech)
Other Related CUSIPS
03211P202
03211P301
Share Statistics
Common Shares Outstanding (M)9.50
Scoring Models
Piotroski F Score2.00
Altman Z ScoreN/A
Beneish M ScoreN/A
Kaplan-Zingales KZ-IndexN/A
Cash Conversion CycleN/A
Per Share Metrics
Additional Paid In Capital Per Share40.81
Inventory Work In Progress Per Share0.00
Deferred Income Tax Liabilities Per Share0.12
Long Term Debt Per Share0.00
Treasury Stock Per Share0.00
Accounts Payable Per Share0.00
Debt Per Share0.00
Inventory Per Share0.00
Equity Per Share0.99
Assets Other Non Current Per Share0.00
Cash And Equivalents Per Share0.79
Intangibles Per Share0.47
Cash Per Share0.79
Retained Earnings Per Share-39.83
Liabilities Current Per Share0.21
Liabilities Per Share0.33
Property Plant And Equipment Per Share0.09
Goodwill Per Share0.00
Assets Current Per Share0.81
Liabilities And Stock Equity Per Share1.40
Current Portion Of Long Term Debt Per Share0.00
Property Plant And Equipment Gross Per Share0.00
Accounts Receivable Per Share0.00
Inventory Raw Materials Per Share0.00
Assets Other Current Per Share0.00
Assets Per Share1.37
Inventory Finished Goods Per Share0.00
Liabilities Other Non Current Per Share0.00
Preferred Stock Value Outstanding Per Share0.00
Assets Non Current Per Share0.00
Accumulated Depreciation And Depletion Per Share0.00
Property Plant And Equipment Net Per Share0.09
Minority Interest Per Share0.00

Related News Stories

Your Daily Pharma Scoop: Portola Ahead Of Catalysts, AstraZeneca Gets 2 FDA Approvals, GW Pharmaceuticals' Price Target Lowered

2017-11-15 seekingalpha
This abridged “Daily Scoop” is published by Avisol Capital Partners, which runs the physician-managed Total Pharma Tracker healthcare investment research service on Seeking Alpha Marketplace. (1487-9)

Your Daily Pharma Scoop: Portola Ahead Of Catalysts, AstraZeneca Gets Two FDA Approvals, GW Pharmaceuticals' Price Target Lowered

2017-11-15 seekingalpha
This abridged “Daily Scoop” is published by Avisol Capital Partners, which runs the physician-managed Total Pharma Tracker healthcare investment research service on Seeking Alpha Marketplace. (1487-2)

AmpliPhi Biosciences' (APHB) CEO Paul Grint on Q3 2017 Results - Earnings Call Transcript

2017-11-15 seekingalpha
Good day and welcome to the AmpliPhi Biosciences Corporation 2017 Third Quarter and Business Update Conference Call. [Operator Instructions] Please note, this event is being recorded. I would now like to turn the conference over to Matt Dansey. Please go ahead. (16-0)

AmpliPhi Biosciences' (APHB) CEO Paul Grint on Q2 2017 Results - Earnings Call Transcript

2017-08-15 seekingalpha
Welcome to the AmpliPhi Biosciences Business Update Call. [Operator Instructions] As a reminder, this conference is being recorded August 15, 2017.

CUSIP: 03211P103